In a report issued on July 6, Eric Coldwell from Robert W. Baird reiterated a Buy rating on AmerisourceBergen Corporation (NYSE: ABC), with a price target of $109. The company’s shares closed yesterday at $88.25.
According to TipRanks.com, Coldwell is a 4-star analyst with an average return of 7.1% and a 54.5% success rate. Coldwell covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Quest Diagnostics Inc, and IQVIA Holdings Inc.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for AmerisourceBergen Corporation with a $103.25 average price target.
See today’s analyst top recommended stocks >>
Based on AmerisourceBergen Corporation’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $287 million. In comparison, last year the company had a net profit of $50.35 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution and Other segments.
